ALFA FinderBSE filing, NSE: VINRKLB. Summary written from the filing by ALFA Finder's alert engine.
Rekvina Laboratories Ltd: key numbers
- Share price
- ₹72.62
- Market cap
- ₹43.78 Cr
- Revenue (annual)
- ₹1.27 Cr
- Net profit (annual)
- ₹-0.25 Cr
- P/E (TTM)
- -122.0×Sector 43.7×
- Promoter holding
- 77.00%+35.70% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rekvina Laboratories Ltd
All →Rekvina Laboratories Q2 FY27 Results: Net Profit ₹0.1 Cr
Rekvina Laboratories Ltd reported revenue from operations of ₹3.6 Cr (+1700.0% YoY) and net profit of ₹0.1 Cr for Q2 FY27.
- Key figure
- Net profit ₹0.1 Cr
Rekvina Laboratories Board Meeting Date
Rekvina Laboratories has scheduled its Board meeting for November 13, 2026, to approve Q2 FY27 un-audited financial results. No material financial figures are disclosed at this stage.
Rekvina Laboratories Business Update
Subsidiary Radiant Parenterals will temporarily shut its manufacturing facility from October 28, 2026. The shutdown supports renovation and installation of an additional vial line.
Rekvina Laboratories Other Announcement
Rekvina Laboratories Limited submitted the certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Rekvina Laboratories Management Change
Rekvina Laboratories Limited has appointed Mr. Subrata Samanta as its new Chief Financial Officer and Key Managerial Personnel, effective October 7, 2026.
Rekvina Laboratories Annual General Meeting
Rekvina Laboratories Ltd held its 38th Annual General Meeting on September 29, 2026, approving financial statements and appointing directors.
Other financial results announcements
All →Team24 Consumer Products Q2 FY27 Results: Net Profit ₹0.3 Cr, Up 200.0% YoY
Team24 Consumer Products Ltd reported revenue from operations of ₹0.5 Cr and net profit of ₹0.3 Cr (+200.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.3 Cr · +200.0% YoY
Transteel Seating Technologies H1 FY27 Results: Net Profit ₹2.8 Cr, Down 72.3% YoY
Transteel Seating Technologies Ltd reported revenue from operations of ₹72 Cr (-7.8% YoY) and net profit of ₹2.8 Cr (-72.3% YoY) for H1 FY27.
- Key figure
- Net profit ₹2.8 Cr · -72.3% YoY
Fusion CX Q2 FY27 Results: Net Profit ₹58.6 Cr, Up 31.1% YoY
Fusion CX Ltd reported revenue from operations of ₹525.3 Cr (+22.1% YoY) and net profit of ₹58.6 Cr (+31.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹58.6 Cr · +31.1% YoY
Vertoz Q2 FY27 Results: Net Profit ₹7.9 Cr, Up 9.7% YoY
Vertoz Ltd reported revenue from operations of ₹83.9 Cr (+16.0% YoY) and net profit of ₹7.9 Cr (+9.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹7.9 Cr · +9.7% YoY
Family Care Hospitals Q2 FY27 Results: Net Loss of ₹0.7 Cr, Loss Widens
Family Care Hospitals reported a quarterly loss before tax of Rs 73.75 lakhs on revenue of Rs 6.65 lakhs. Half-year loss before tax was Rs 116.12 lakhs.
- Key figure
- Net loss ₹0.7 Cr
Sarveshwar Foods Q2 FY27 Results: Net Profit ₹8.4 Cr, Up 2.4% YoY
Sarveshwar Foods Ltd reported revenue from operations of ₹356.1 Cr (+6.3% YoY) and net profit of ₹8.4 Cr (+2.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹8.4 Cr · +2.4% YoY